Member Info for 86KB

Come 11, I would think we would be trading closer to 7s.

There you go back above 5s

Buying under 5p will be gone soon, will be back above 5p soon imo.

News would have been digested properly yesterday. Many would have sold due to placing fears but they don't need to raise.

Remember first in class in a $100Billion+ industry. Diagnostic deals have been done in billions. Won't be long until deal comes but in the meantime would expect this to rerate to double digits.

Would think that huge gap gets filled at some point between 50p and £1.47.

Im sure many would have read the news again and digested its properly. Some may have sold due to fears of a raise even though they wouldn't need to.

The diagnostic market is worth billions and to be the first in an area where is in high demand with deals being done in billions this is just the start of journey.

"This combination makes P140 a unique and extremely valuable asset , particularly with the potential for 20 years of commercial exclusivity, and will add enormous traction to our current discussions with potential global partners of P140,"

The global autoimmune therapeutics market is valued at over $100 billion and is forecast to reach approximately $360 billion by 2030, indicating significant financial potential. There have been 11 relevant therapy product licensing deals averaging $1bn total deal value in last 2 years.

There is no one, I repeat absolutley no one else who has the P140 treatment. Its completely new, they are first in class with this treatment. There is a major need for effective treatment with safety. Unlike current therapies P140 is effective and safe "findings confirm P140’s potential as a safe and effective treatment for patients suffering from systemic lupus erythematosus"

Now think how much is that worth globally. Yes we may see fluctuation in share price but come year end would expect many multiples from current levels.

Patent filed is a huge milestone, expect commercial deals next.

Mixture of buys and sells there, lets see where we are at by end of week.

Great close at 4.8p, tomorrow we go higher.

Some order got filled there, sudden jump to 4.75 to buy now.

The 1 trade

Well theres a 3rd code 1, 2 of them we had news already.

I guess we will get an interview to clear any doubt about patent filing as I don't think some realise how big this patent filing is. Currently negotiations are taking place and expect them to conclude shortly.

US market closed today and usually we would have seen a huge jump here if they were opened. Tomorrow going to be an interesting day. A close between 5-6p today will be great.

Filling the patent is a huge step and deals can still take place. They have been in discussions at various levels since last year and the ceo mentioned this was going to be a transformational year with deals to be concluded this year.

The new patent filing provides the potential for 20 years of commercial exclusivity for both the diagnostic test and P140 therapy, positioning ImmuPharma as a LEADER in the next generation of autoimmune disease treatments.

therapeutic market valued at over $100 billion annually.

CURRENT treatments remain limited and often unsafe, highlighting a major unmet medical need

ImmuPharma's novel diagnostic test, designed to identify patients with Type M immune disorder, not only strengthens the value proposition of P140 but also creates an independent commercial opportunity with potential for earlier adoption and partnerships.

With this dual platform - FIRST IN CLASS therapy plus precision diagnostic - ImmuPharma is pioneering a new era of precision medicine in autoimmune disease, offering ACCURATE diagnosis and a GROUNDBREAKING treatment with the POTENTIAL to achieve FULL REMISSION.

As we continue to move forward on the next step of our corporate journey, which is the partnering and commercialisation of our product portfolio, P140 in particular, it is important that our R&D team is at the forefront of our interactions and negotiations with current and future commercial partners

Look at the mcap vs what is coming here. Some are loading up and taking advantage. Whilst some sell thinking they will get back in cheaper.

Well whilst a few keep talking about a raise, what if a deal lands this week?

Maverick you mentioned a pullback to 2.6 earlier but you never got it. We held well in 3s and now we are consolidating before a push into close. Should see a close above 5p and carry on building tomorrow.

Remember autoimmune disease treatment is in high demand and deals have been done over $1 billion. These will be trading in £1+ at some point.

Well Ceo mentioned we should be trading at an mcap of £350-500m already based on others at similar stages.

As we continue to move forward on the next step of our corporate journey, which is the partnering and commercialisation of our product portfolio, P140 in particular, it is important that our R&D team is at the forefront of our interactions and negotiations with current and future commercial partners